stocks logo

RGLS Financial Analysis

Regulus Therapeutics Inc
$
1.600
-0.085(-5.040%)

RGLS Financial Analysis

FY2024Q4FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Total Revenue
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
0.00
-100.00%
5.00M
27677.78%
5.00M
27677.78%
0.00
-100.00%
6.00K
Revenue from Goods & Services
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
0.00
-100.00%
5.00M
27677.78%
5.00M
27677.78%
0.00
-100.00%
6.00K
Gross Profit
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
0.00
-100.00%
5.00M
27677.78%
5.00M
27677.78%
0.00
-100.00%
6.00K
Selling General & Administrative Expenses
13.75M
65.61%
15.21M
87.20%
12.26M
67.60%
8.83M
19.77%
8.30M
19.73%
8.13M
7.43%
7.32M
1.95%
7.37M
12.18%
6.93M
-0.40%
7.56M
-10.17%
7.18M
8.09%
6.57M
13.30%
6.96M
15.44%
8.42M
38.13%
6.64M
2.19%
5.80M
4.64%
6.03M
35.39%
6.10M
21.63%
6.50M
38.63%
5.54M
Research & Development Expense
9.67M
69.48%
11.28M
106.82%
8.24M
66.50%
5.98M
22.07%
5.71M
21.76%
5.45M
3.16%
4.95M
5.68%
4.90M
33.86%
4.69M
7.23%
5.29M
-10.13%
4.68M
13.97%
3.66M
22.42%
4.37M
13.53%
5.88M
49.80%
4.11M
-0.36%
2.99M
-0.37%
3.85M
95.53%
3.93M
68.79%
4.12M
145.48%
3.00M
Operating Profit
-13.75M
65.61%
-15.21M
87.20%
-12.26M
67.60%
-8.83M
19.77%
-8.30M
19.73%
-8.13M
7.43%
-7.32M
1.95%
-7.37M
12.18%
-6.93M
-0.40%
-7.56M
-10.17%
-7.18M
8.09%
-6.57M
13.30%
-6.96M
576.38%
-8.42M
668.86%
-6.64M
2.19%
-5.80M
4.75%
-1.03M
-76.80%
-1.10M
-78.07%
-6.50M
39.16%
-5.54M
Financing Income- Net
955.00K
299.58%
1.15M
281.40%
1.23M
304.29%
357.00K
55.22%
239.00K
74.45%
301.00K
2408.33%
303.00K
-465.06%
230.00K
-254.36%
137.00K
-179.19%
12.00K
-105.74%
-83.00K
-113.72%
-149.00K
-30.70%
-173.00K
-39.51%
-209.00K
-51.17%
605.00K
-234.15%
-215.00K
-47.56%
-286.00K
-37.55%
-428.00K
-0.47%
-451.00K
29.97%
-410.00K
Interest Expense
-955.00K
299.58%
-1.15M
281.40%
-1.23M
304.29%
-357.00K
55.22%
-239.00K
74.45%
-301.00K
2408.33%
-303.00K
-465.06%
-230.00K
-254.36%
-137.00K
-179.19%
-12.00K
-105.74%
83.00K
-113.72%
149.00K
-30.70%
173.00K
-39.51%
209.00K
-51.17%
-605.00K
-234.15%
215.00K
-47.56%
286.00K
-37.55%
428.00K
-0.47%
451.00K
29.97%
410.00K
Income before Taxes
-12.79M
58.68%
-14.06M
79.73%
-11.04M
57.37%
-8.47M
18.63%
-8.06M
18.63%
-7.82M
3.62%
-7.01M
-3.39%
-7.14M
6.27%
-6.80M
-4.74%
-7.55M
-12.48%
-7.26M
20.30%
-6.72M
11.72%
-7.13M
442.43%
-8.63M
466.51%
-6.03M
-13.16%
-6.01M
1.14%
-1.32M
-73.12%
-1.52M
-71.92%
-6.95M
38.52%
-5.95M
Income Taxes
0.00
0.00
1,000
0.00%
0.00
0.00
0.00
1,000
0.00
-100.00%
0.00
0.00
0.00
-100.00%
1,000
0.00
-100.00%
0.00
-100.00%
1,000
0.00
-100.00%
7.00K
1,000
0.00
-100.00%
-8.00K
Net Income after Tax
-12.79M
58.68%
-14.06M
79.73%
-11.04M
57.36%
-8.47M
18.63%
-8.06M
18.63%
-7.82M
3.62%
-7.01M
-3.38%
-7.14M
6.25%
-6.80M
-4.74%
-7.55M
-12.48%
-7.26M
20.29%
-6.72M
11.74%
-7.13M
439.56%
-8.63M
466.14%
-6.03M
-13.14%
-6.01M
1.28%
-1.32M
-72.98%
-1.52M
-71.90%
-6.95M
38.50%
-5.94M
Income Available to Common Shares
-12.79M
58.68%
-14.06M
79.73%
-11.04M
57.36%
-8.47M
18.63%
-8.06M
18.63%
-7.82M
3.62%
-7.01M
-3.38%
-7.14M
6.25%
-6.80M
-4.74%
-7.55M
-12.48%
-7.26M
20.29%
-6.72M
11.74%
-7.13M
439.56%
-8.63M
466.14%
-6.03M
-13.14%
-6.01M
1.28%
-1.32M
-72.98%
-1.52M
-71.90%
-6.95M
38.50%
-5.94M
EPS - Basic
-0.20
-50.00%
-0.21
-47.50%
-0.17
-54.05%
-0.29
-30.95%
-0.40
-0.00%
-0.40
-20.00%
-0.37
-26.00%
-0.42
-8.70%
-0.40
-40.30%
-0.50
-49.49%
-0.50
-35.90%
-0.46
-45.24%
-0.67
139.29%
-0.99
147.50%
-0.78
-66.52%
-0.84
-65.99%
-0.28
-87.98%
-0.40
-84.62%
-2.33
-22.33%
-2.47
EPS - Diluted
-0.20
-50.00%
-0.21
-47.50%
-0.17
-54.05%
-0.29
-30.95%
-0.40
-0.00%
-0.40
-20.00%
-0.37
-26.00%
-0.42
-8.70%
-0.40
-40.30%
-0.50
-49.49%
-0.50
-35.90%
-0.46
-45.24%
-0.67
139.29%
-0.99
147.50%
-0.78
-66.52%
-0.84
-65.99%
-0.28
-87.98%
-0.40
-84.62%
-2.33
-22.33%
-2.47
EBIT
-13.75M
65.61%
-15.21M
87.20%
-12.26M
67.60%
-8.83M
19.77%
-8.30M
19.73%
-8.13M
7.43%
-7.32M
1.95%
-7.37M
12.18%
-6.93M
-0.40%
-7.56M
-10.17%
-7.18M
8.09%
-6.57M
13.30%
-6.96M
576.38%
-8.42M
668.86%
-6.64M
2.19%
-5.80M
4.75%
-1.03M
-76.80%
-1.10M
-78.07%
-6.50M
39.16%
-5.54M
EBITDA
-13.66M
66.09%
-15.12M
87.38%
-12.17M
67.46%
-8.75M
19.45%
-8.22M
19.21%
-8.07M
7.14%
-7.27M
1.74%
-7.32M
11.89%
-6.90M
1.17%
-7.53M
-10.14%
-7.14M
8.36%
-6.54M
19.77%
-6.82M
1012.40%
-8.38M
754.33%
-6.59M
3.44%
-5.46M
1.00%
-613.00K
-85.53%
-981.00K
-79.84%
-6.37M
41.74%
-5.41M
Depreciation Depletion & Amortization
87.00K
14.47%
90.00K
60.71%
89.00K
89.36%
81.00K
68.75%
76.00K
130.30%
56.00K
75.00%
47.00K
51.61%
48.00K
84.62%
33.00K
-76.60%
32.00K
-15.79%
31.00K
-31.11%
26.00K
-92.24%
141.00K
-66.11%
38.00K
-66.67%
45.00K
-63.11%
335.00K
165.87%
416.00K
108.00%
114.00K
-10.24%
122.00K
-28.65%
126.00K

RGLS FAQs

What is RGLS's PE Ratio in 2025/4/4?

RGLS's PE ratio in April 4, 2025 is -2.05. This indicates the price investors are willing to pay for $1 of earnings.

What is RGLS's PS Ratio in 2025/4/4?

What is RGLS's Dividend Yield in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is RGLS earnings result positive or negative?How should I trade on RGLS earnings?